Search hospitals > California > San Francisco
UCSF Medical Center-Mount Zion
Claim this profileSan Francisco, California 94115
Global Leader in Thyroid Cancer
Global Leader in Relapse
Conducts research for Stomach Cancer
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Uterine Tumors
154 reported clinical trials
11 medical researchers
Summary
UCSF Medical Center-Mount Zion is a medical facility located in San Francisco, California. This center is recognized for care of Thyroid Cancer, Relapse, Stomach Cancer, Human Immunodeficiency Virus Infection, Uterine Tumors and other specialties. UCSF Medical Center-Mount Zion is involved with conducting 154 clinical trials across 281 conditions. There are 11 research doctors associated with this hospital, such as Pamela Munster, Sue S. Yom, Steven N. Seyedin, and Joel Palefsky, MD.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
p16 positive
2Relapse
Global LeaderBRAF positive
BRAF negative
Stage IV
Top PIs
Pamela MunsterUniversity of California, San Francisco4 years of reported clinical research
Studies Solid Tumors
Studies Uterine Tumors
18 reported clinical trials
32 drugs studied
Sue S. YomUniversity of California, San Francisco3 years of reported clinical research
Studies Thyroid Cancer
Studies Squamous Cell Carcinoma
10 reported clinical trials
20 drugs studied
Steven N. SeyedinUC Irvine Health/Chao Family Comprehensive Cancer Center4 years of reported clinical research
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
5 reported clinical trials
16 drugs studied
Joel Palefsky, MDUniversity of California, San Francisco1 year of reported clinical research
Studies HIV/AIDS
Studies Anal Intraepithelial Neoplasia
5 reported clinical trials
13 drugs studied
Clinical Trials running at UCSF Medical Center-Mount Zion
Prostate Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Oropharyngeal Cancer
Laryngeal Squamous Cell Carcinoma
Skin Cancer
Thyroid Cancer
Oral Squamous Cell Carcinoma
Throat Cancer
Prostate Adenocarcinoma
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UCSF Medical Center-Mount Zion?
UCSF Medical Center-Mount Zion is a medical facility located in San Francisco, California. This center is recognized for care of Thyroid Cancer, Relapse, Stomach Cancer, Human Immunodeficiency Virus Infection, Uterine Tumors and other specialties. UCSF Medical Center-Mount Zion is involved with conducting 154 clinical trials across 281 conditions. There are 11 research doctors associated with this hospital, such as Pamela Munster, Sue S. Yom, Steven N. Seyedin, and Joel Palefsky, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.